NTAGI approves SII's Covovax COVID vaccine for 12-17 age group: Sources

Apr 29, 2022

New Delhi [India], April 29 : National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for...

SEC recommends granting emergency use authorisation to Serum Institute of India's Covovax COVID-19 vaccine

Mar 04, 2022

New Delhi [India], March 4 : The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19...

SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-12 age group: Sources

Apr 29, 2022

New Delhi [India], April 30 : The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based...

Adar Poonawalla clarifies COVID-19 vaccine Covovax available for everyone above age of 12 years

May 05, 2022

Pune (Maharashtra) [India], May 5 : Chief Executive Officer of Pune based Serum Institute of India Adar Poonawalla on Wednesday clarified that the COVID-19...

Moderna says its COVID-19 vaccine 100 per cent effective in 12-17 age group

May 25, 2021

Washington [US], May 25 : Moderna on Tuesday announced that various studies have shown its COVID-19 vaccine was 100 per cent effective at preventing...

DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years

Mar 09, 2022

New Delhi [India], March 9 : The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of...